Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is

Journal of Clinical Epidemiology

Volumn 60, Issue 6, 2007, Pages 547-553

  Tumanan Mendoza, Bernadette A ^a   Dans, Antonio L ^b   Villacin, Lourdes Lucienne ^c   Mendoza, Victor L ^d   Rellama Black, Sofia ^e   Bartolome, Moises ^f   Ragual, Jimmy ^f   Flor, Benjamin ^g   Valdez, Josephine ^d  

^a Manila Doctors Hospital   (Philippines)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c Riverside Medical Center   (Philippines)

^d Salle University   (Philippines)

^e SAINT LOUIS UNIVERSITY   (Philippines)

^f Department of Medicine   (Philippines)

^g NONE

Author keywords

ACE inhibitors; Cough; Dechallenge rechallenge method; Randomized trial

Indexed keywords

CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; IMIDAPRIL; PERINDOPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CILAZAPRIL; COUGH; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLIDINES; INCIDENCE; MALE; MIDDLE AGED; PERINDOPRIL; PHILIPPINES; TREATMENT OUTCOME;

EID: 34247579963     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.06.017     Document Type: Article

References (17)

1. Punzi H.A. Safety update: focus on cough. Am J Cardiol 72 (1993) 45H-48H
2. Chalmers D., Whitehead A., and Lawson D.H. Postmarketing surveillance of captopril for hypertension. Br J Clin Pharmacol 34 (1992) 215-234
3. Degante J.P., Leeman M., and Desche P. Longterm acceptability of perindopril: European multicenter trial on 856 patients. Am J Med 92 4B (1992) 845-905
4. Strocchi E., Valtancoli G., and Ambrosioni E. The incidence of cough during treatment with ACE-Inhibitors. J Hypertens 7 (1989) S308-S309
5. Yeo W.W., and Ramsay L.E. Persistent dry cough with enalapril: incidence depends on methods used. J Hum Hypertens 4 (1990) 517-520
6. Israili Z.H., and Hall W.D. Cough and angioneurotic edema associated with ACE-Inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 117 (1992) 234-242
7. Woo J., and Chan T.Y. A high incidence of cough with combination therapy of hypertension with isradipine and lisinopril in Chinese subjects. Br J Clin Pract 45 (1991) 178-180
8. Ravid D., Lishver M., Lang R., and Ravid M. ACE-Inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol 34 (1994) 1116-1120
9. Elliot W.J. Higher incidence of discontinuation of ACE-Inhibitors due to cough in black subjects. Clin Pharmacol Ther 60 (1996) 582-588
10. Woo K.S., Norris R.M., and Nicholls G. Racial difference in the incidence of cough with ACE-Inhibitors. A tale of two cities. Am J Cardiol 75 (1995) 967-968
11. Lacourciere Y., Brunner H., Irwin R., Karlberg B.E., Ramsay L.E., Snavely D.B., et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens 12 12 (1994) 1387-1393
12. Semple P.F. Putative mechanism of cough after treatment with ACE-Inhibitors. J Hypertens Suppl 13 S3 (1995) S17-S21
13. Lalloo U.G., Barnes P.J., and Chung K.F. Pathophysiology and clinical presentation of cough. J Allergy Clin Immunol 98 5PT (1996) S91-S96 discussion S96-97
14. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). National Institutes of Health. National Institutes of Health Publication 1997 (Nov).
15. Oberg K. Adverse drug reactions. Am J Pharma Educ 63 (1999) 199-203
16. Yesil S., Yesil M., Bayata S., and Postaci N. Ace inhibitors and cough. [abstract]. Angiology 45 (1994) 805-808
17. New medicines on the market. Imidapril. Evaluated information for NHS managers, budget holders and prescribers. UK drug information pharmacists group. Aug 1999. Monograph No. 4/99/12.